Literature DB >> 8126507

Iron status, movement disorders, and acute phase response in elderly psychiatric patients.

A J Treloar1, M A Crook, P Tutt, D P White, M P Philpot.   

Abstract

The previously reported relation between iron deficiency and movement disorders was studied in a population with a high prevalence of both problems. There was no evidence of a direct statistical relation between iron deficiency and movement disorders. Significant associations were, however, found between movement disorders and features of the acute phase response to physiological stress. Indices of iron status are known to be affected by the acute phase response and it is suggested that the previously reported abnormalities in iron status may be secondary to this.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126507      PMCID: PMC1072452          DOI: 10.1136/jnnp.57.2.208

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

Review 1.  The value of acute phase protein measurements in clinical practice.

Authors:  D Thompson; A Milford-Ward; J T Whicher
Journal:  Ann Clin Biochem       Date:  1992-03       Impact factor: 2.057

2.  Serum iron and transferrin in acute neuroleptic induced akathisia.

Authors:  V O'Loughlin; A C Dickie; K P Ebmeier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

3.  Low plasma iron status and akathisia.

Authors:  A Barton; J Bowie; K Ebmeier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

4.  Diagnostic methods for iron status.

Authors:  I Cavill; A Jacobs; M Worwood
Journal:  Ann Clin Biochem       Date:  1986-03       Impact factor: 2.057

5.  Low serum iron status and akathisia.

Authors:  K W Brown; S E Glen; T White
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

6.  Serum iron and neuroleptic malignant syndrome.

Authors:  P I Rosebush; M F Mazurek
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

7.  Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.

Authors:  V Baracos; H P Rodemann; C A Dinarello; A L Goldberg
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

8.  A rating scale for tardive dyskinesia.

Authors:  G M Simpson; J H Lee; B Zoubok; G Gardos
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

9.  Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms.

Authors:  J L Waddington; H A Youssef
Journal:  Br J Psychiatry       Date:  1986-11       Impact factor: 9.319

10.  Tardive dyskinesia and type II schizophrenia.

Authors:  E J Davis; M Borde; L N Sharma
Journal:  Br J Psychiatry       Date:  1992-02       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.